chrisvoncsefalvay/vaers-outcomes huggingface dataset:
patient under 18 years of age, has been given the first dose of Moderna vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (patient under 18 years of age, has been given the first dose of Moderna vaccine) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (patient under 18 years of age, has been given the first dose of Moderna vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (patient under 18 years of age, has been given the first dose of Moderna vaccine) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment information was not provided.; Sender's Comments: This report refers to a case of product administered to patient of inappropriate age (17 year old female) for mRNA-1273 (lot number 040A21A) with no associated AEs reported.
Swelling, redness, warmth, hard knot at site.  Swelling at 6 in diameter by 06 3/6/14.  Rec'd IV Benadryl 50 mg without much relief or decrease in sx.  Cool compress applied.
received the first GARDASIL 9 dose in 2014 on an unknown month; Information has been received from a pharmacist concerning a 21-year-old female patient. The patient's concurrent conditions, pertinent medical history, drug allergies/drug reactions and concomitant medications were not provided.  It was reported that on unspecified day in 2014, the patient was vaccinated with her first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (dose, route, Lot # and expiration date not reported) and on 20-JUL-2020 the patient was vaccinated with the second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (dose, route, Lot # and expiration date not reported) by another health care professional for prophylaxis.
Resident received Pneumovax 0.5cc IM injection on 4/3/2006 in right upper arm. Area of 20cm x 27cm reported to be red, swollen, warm to touch. Resident complained of pain in area. Reaction noted by nurse 4/5/06.
Red raised rash starting around vaccine site and spreading downward over a few days.  Warm to touch.
This spontaneous case was reported by a patient and describes the occurrence of JOINT SWELLING (Ankles were swollen), DECREASED APPETITE (Lost appetite), ABDOMINAL PAIN (Some pain in the abdominal area), ARTHRALGIA (Knee pain/Up until now when the patient walks, slight has ankle and knee pain) and PAIN IN EXTREMITY (Sharp pain in both arms/Still slight pain in arms and hands) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 059A22A, 031H21A, 002B21A and 011M20A) for COVID-19 prophylaxis.  Allergies: none and the patient medical history was provided as none.  On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form On 25-Jun-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2022, the patient experienced DECREASED APPETITE (Lost appetite). On 25-Jun-2022, the patient experienced JOINT SWELLING (Ankles were swollen), ABDOMINAL PAIN (Some pain in the abdominal area), ARTHRALGIA (Knee pain/Up until now when the patient walks, slight has ankle and knee pain) and PAIN IN EXTREMITY (Sharp pain in both arms/Still slight pain in arms and hands). At the time of the report, JOINT SWELLING (Ankles were swollen), ARTHRALGIA (Knee pain/Up until now when the patient walks, slight has ankle and knee pain) and PAIN IN EXTREMITY (Sharp pain in both arms/Still slight pain in arms and hands) was resolving, DECREASED APPETITE (Lost appetite) outcome was unknown and ABDOMINAL PAIN (Some pain in the abdominal area) had not resolved. The patient never had COVID positive test or diagnosis. It was reported that no other vaccines were given within one month prior to Moderna COVID-19 vaccine. No concomitant medications were reported. It was reported by the patient that everything had went well after two Moderna doses and first booster. On 22-Jun-2022, the patient went to see doctor, who told to get the patient a second booster. As the patient was leaving the pharmacy, the patient noticed that ankles were swollen, and had knee pain. It was getting worse than better, so the patient went back to the doctor that took well over a month for the swelling to go down. It was further reported that for the first day or two, there was a sharp pain in both arms, but it disappeared. The patient had pain in the abdominal area, which the patient never had in the past. The patient never had difficulty with legs at all. It was also reported that for the pain (knee, arm, hand, abdominal area), the patient had to seek medical care and had a doctor call on 25-Jun-2022 and these symptoms had improved but still going. No treatment medications were reported.
Ten minutes after receiving influenza vaccine felt dizzy and syncopal, he fell to the ground and bruised nose and cut lip. He was given O2  then transferred to ER and given IV fluids.
pt recv vax 17OCT96 & the next day 18OCT pt devel puffiness around the eyes & face accompanied by a small, itchy facial rash;
pt recv vax 2OCT95 & 20MAY97 pt devel scattered vesicles & papules on erythematous base consistent w/varicella;
Initial unsolicited report received from a physician on 12 September 2016. This case involves a female patients (age not reported) who was vaccinated with a dose of DIPHTHERIA, TETANUS AND ACELLULAR PERTUSSIS VACCINE (DtaP vaccine) (batch number, expiry date, dose, route and site of administration were not reported) on unspecified date. Illness at time of vaccination and pre-existing physician diagnosed allergies, birth defects, medical conditions was reported as unknown. Concomitant medications were reported as unknown. On an unspecified date (reported as 15 years ago), following the vaccination, patient experienced migraines. Lab data and corrective treatment were not reported. The outcome of event reported as unknown. List of documents held by sender: none.
Approximately 24 hours after receiving the shot I was achy.  This lasted for the afternoon and evening.  I did not feel comfortable when I went to bed at midnight so I took Tylenol to treat the achiness.  I was able to fall asleep and feltuch better the next morning.
on 3rd day after shot, patient experienced sweating, shivers, dizziness, incoordination, "TIA"
Severe fever reaching 102 degrees and sustained illness for 4 days post vaccination.  Cold sweats and chills were frequent with significant soreness to impair ability to work.  NSaids and Acetaminophen were unable to break the fever until the 4th day.
I had  a slight itchiness of neck under the bottom edge of my mask about 10-15 minutes after shot that went away while at the vaccine location. I thought it might of just been from the mask at the time but the paramedic checked me and I was fine. Left the location after 30 minutes.  Had  sudden dizziness/vertigo-  about 3 1/2 hours  later- Stood up and suddenly room was spinning briefly, then just had difficulty walking because of vertigo but room was not spinning then. I needed my husband to help me walk to the couch so I could lie down.  I started feeling strongly nauseous and held a bag near me as felt would vomit but never did. I sipped on water/gatorade and then started to feel better after- 30-45 minutes the nausea started to subside as well as the vertigo.  After about 2 1/2  hours the vertigo had greatly decreased and was able to eat a light dinner and walk around  and felt okay. I felt fine since then.  I let my primary care doctor know about it later.
Lethargy, tiredness, redness (in injection arm that persisted after 4 days), pain-that I would describe as moderate to severe, fever (ranging from 99-101)
Nausea, severe vomiting, chills, hot, sweating profusely, upset stomach.  Tired and achy. Symptoms severe day 1.  Less severe days 2-3 after vax.
Lethargic; This is a spontaneous report from a non-contactable consumer (patient) via Pfizer sponsored program. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unspecified date as single dose for COVID-19 immunization. Medical history and concomitant medications were not provided. The patient experienced lethargic for 1 day. Outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Getting your period a day after even though already got it; This spontaneous case was reported by a consumer and describes the occurrence of MENSTRUAL DISORDER (Getting your period a day after even though already got it) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MENSTRUAL DISORDER (Getting your period a day after even though already got it). At the time of the report, MENSTRUAL DISORDER (Getting your period a day after even though already got it) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication list was not provided. Treatment information was not provided.
The patient was taken to the ER with a fever of 104.5F (rectal) and difficulty breathing. The patient was diagnosed with acute febrile reaction due to vaccines. The patient was treated with Tylenol.
Severe pain in the shoulder radiating to the spine and down the arm to the elbow more severe during the 2 nights following vaccination. Slight impairment in arm mobility (lifting laterally and over the head) next day, more severe after 48h. Severe lower back pain, persistent. Now (1/3/22) there is very little pain but there is no improvement in arm function. Cannot lift over the head at all. Laterally I can lift it only partially. Back pain persists. On day 2 I asked for advice from a colleague who is a neurologist. She suspects inflammation in the deltoid; demyelination is unlikely. Taken tylenol ~ 30 ml/day.
she's scheduled for the second dose tomorrow, because she doesn't get any medications and she doesn't want to get sick.; Her leg has been hurting from the knee down and also her arm is aching a little,; She was feeling extremely tired; She had a really bad headache; Sinus problems; Her leg has been hurting from the knee down and also her arm is aching a little,; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A 73 year-old female patient received bnt162b2 (BNT162B2), administration date 07Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Leg problems" (unspecified if ongoing), notes: She said she had leg problems before getting her first shot. The patient's concomitant medications were not reported. The following information was reported: FATIGUE (non-serious) with onset Apr2021, outcome "unknown", described as "She was feeling extremely tired"; HEADACHE (non-serious) with onset Apr2021, outcome "unknown", described as "She had a really bad headache"; SINUS DISORDER (non-serious) with onset Apr2021, outcome "unknown", described as "Sinus problems"; ARTHRALGIA (non-serious), PAIN IN EXTREMITY (non-serious) all with onset Apr2021, outcome "unknown" and all described as "Her leg has been hurting from the knee down and also her arm is aching a little,"; CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (non-serious), outcome "unknown", described as "she's scheduled for the second dose tomorrow, because she doesn't get any medications and she doesn't want to get sick.".  Additional information: Caller received the first dose of the Pfizer-BioNtech Covid-19 vaccine on 07Apr2021, for the next week she had a really bad headache but she was also dealing with sinus problems. Her leg had been hurting from the knee down and also her arm was aching a little, also she had been feeling extremely tired. She would like to know if she should receive the second dose of the vaccine, she was scheduled for the second dose tomorrow, because she did not get any medications and she did not want to get sick.  No follow-up attempts are possible. No further information is expected.
Right sided heaviness and left facial droop that was transient.  Patient had no further symptoms until 12/16/2015 at 10:38 PM when he was found to be having a probable absence seizure.  He was again seen in the ED and CT scan of head was normal. He has no previous history of seizures.
24 hours post MMR (given 11/13/2006) started having explosive diarrhea 3-4 times a day with a sporadic high fever of 101-102degrees. This is still happening on a daily basis. All lab work has proven normal blood counts.
Golf ball-sized swelling, tenderness and redness at injection site. Muscle soreness of arm near injection site.
Pt recv vax on 10/14/97; immediately post vax pt exp dyspnea, nausea & swollen/red/warmth area from shoulder to elbow; tx=Benadryl, Solu Medrol, Depo Medrol, Elocon cream
Severe stabbing, throbbing headaches for four days which had no relief from Tylenol, Ibuprofen, Excederin, Ice or Heatpack. I went to the ER Thursday Feb 11th.   Diagnosed with Vaccine reaction and diagnosed with Paroxysmal Hemicrania
ON 10/25/11 TELEPHONE CALL RECEIVED FROM PT C/O DEVELOPED RASH TO (R) (L) SIDE OF NECK. THE FOLLOWING DAY STATED HER DAUGHTER WAS THE ONE NOTICED IT. C/O ITCHING. 10/28/11 - CLIENT ASSESSED - SLIGHT RASH TO LET SIDE NECK - APPLIED CORTISONE TO AREA WHICH RELIEVED ITCHING.
Redness and swelling at site of injection. Tx cephalexin (L) thigh.
This spontaneous report as received from a nurse practitioner refers to a 60 year old female patient. On approximately 20-SEP-2013 (reported as two weeks ago) the patient was vaccinated with ZOSTAVAX in her left deltoid, in pharmacy (dose, lot number and expiration date were not reported). Concomitant therapies included aspirin. On 22-SEP-2013, two days after being administered ZOSTAVAX the patient developed a rash. The rash on her right and left hip was about 6 centimeters in width and 13 centimeters in length and it was raised, red and itchy. The rash near her left eye was red with papules. The rash was in unspecified locations on her upper extremities and looked like scratches. The nurse believed that the rash was some kind of contact dermatitis because the patient reported spending time in a wooded area on an unspecified date about 4 days after ZOSTAVAX was administered. The patient's rash was treated with ATARAX and unspecified topical hydrocortisone cream. No lab diagnostic studies were performed. The patient sought medical attention and she went to a nurse practitioner. At the time of this report the patient did not recover from her adverse events. Follow up information was received from the reporting nurse. The patient's medical history included exposure to shingles (reported as months ago). A rash did not occur at the site of injection post-vaccination. On 03-OCT-2013 the patient experienced large, raised, erythremic wheel with small papular satellite lesions over left hip. The lesions were distributed on hip, arms, chin and eyelid. Number of lesions was reported as five. The patients outcome was not reported. The relatedness between the patient's adverse events and the vaccination with ZOSTAVAX was not reported. Additional information is not expected.
Rash (bumps) approx. 2-3 inches in diameter around injection site.
After a couple of days of receiving second dose of covid vaccine, I experienced very high rate of premature ventricular contractions PVCs - cardiologist found normal echocardiogram but 7-day cardiac a; This is a spontaneous report received from a contactable consumer (patient himself). A 47-year-old male patient bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/lot number: Unknown and Expiry Date: Unknown) via unspecified route of administration on 01May2021, (at the age of 47-years-old) as Dose 2, Single for COVID-19 immunization. Historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/lot number: Unknown and Expiry Date: Unknown) via unspecified route of administration on an unspecified date (at the age of 47-years-old) as Dose 1, Single for COVID-19 immunization.Patient's medical history and concomitant medications were not reported. He had no known allergies.The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and no other medications within 2 weeks of vaccination. After a couple of days of receiving second dose of COVID vaccine, on 05May2021, he experienced very high rate of premature ventricular contractions PVCs; cardiologist found normal echocardiogram but on 7-day cardiac ambulant EKG monitor showed PVCs at 6% of the time.The adverse events caused doctor or other healthcare professional office/clinic visit. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.Treatment regimen was not given as a result of the adverse events. The patient underwent lab test which included ECG monitoring on unspecified dates.Device date was given reported as 22Jun2021.The outcome of event was recovered on an unspecified date.   Information about lot/Batch number has been requested.; Sender's Comments: Based on the current available information and the consistency with the known safety profile of the suspect product BNT162B2, there is a reasonable possibility that event ventricular extrasystole were related to suspect drug based on the temporal relation between the vaccination and onset of events. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Patient received Pfizer vaccine as second dose. Patient first vaccine dose was Moderna. Received 3/1/2021
The pt felt weak and fainted for 2-3 seconds. This happened 1-2 minutes after immunization. The pt took 1-2 sips of Coke and recovered.
Pt. reported soreness around injection site after 1 day. Then around day 2 or 3 started developing a rash. On day 4 pt. presented to pharmacy. Rash was on a large area of upper arm and pt. complained of itching. Now reporting on day 4.
For a short time, thirty seconds or so, I was unable to control the fingers of my right hand, ordering them to pick up a small object. I stared at my hand willing it to move but it would not. I felt out of sorts, took a nap for an hour, and all is well now.
No additional AE/PQCs reported.; Caller reported the administration of Improperly Stored PROQUAD.; This spontaneous report was received from a consumer, referring to him/herself as a patient of unknown age and gender. The patient's pertinent medical history, current conditions, previous drug reactions or allergies and concomitant medications were not provided.   On 20-NOV-2020, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD), as prophylaxis (formulation, strength, dose, vaccination scheme, route of administration and anatomical site of vaccination were not reported; lot number T021639, which has been verified to be valid, expiration date reported an validated as 21-12-2021). The vaccine administered experienced a temperature excursion of -10 to 8 degrees Celsius (C) (-5.6C), for a time frame of 1 hour and 32 minutes as recorded by a data logger. There was no previous temperature excursion reported. No additional adverse events were reported.
This spontaneous report as received from a nurse refers to multiple patients of unknown age and gender. The patients' pertinent medical history and drug reactions or allergies were not reported. On an unknown date, the patients were vaccinated with an improperly stored dose of RECOMBIVAX HB (dose and route were not reported, lot # K008334, expiry date: 09-JUN-2016). Concomitant medications were not reported. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
pt. vax'd w/ 1st dose of hepatitis B vac & exp. aching of the arms,followed by generalized muscle aches & pain, & diarrhea.
Information has been received from an unspecified reporter referring to an 11 year old patient of unknown gender. The patient's concomitant medication, concurrent conditions and medical history were not reported. On 13-SEP-2016, the patient was vaccinated with GARDASIL 9 (lot #, expiration date, dose and route were not reported) for prophylaxis. The vaccine was administered at a Heath Center during the temperature excursion. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1612USA003650.
Right ear ringing since my 3rd shot (booster), on 2/21/22
Information has been received from a physician concerning an adult patient who on an unspecified date was vaccinated with a dose of ZOSTAVAX (Merck) (dose, route and lot number not provided). It was reported that at an unknown time frame after receiving ZOSTAVAX (Merck), the patient developed shingles. At the time of the report the patient's outcome was unknown. Follow-up information was received from the physician concerning the 64 year old male with a history of chickenpox at childhood and no recent exposure to chickenpox or herpes zoster who on 01-JUL-2011 was vaccinated subcutaneously into the right arm (also reported as into the left arm) with a dose of ZOSTAVAX (Merck) (lot number 02188AA (Lot number 02188AA is an invalid lot number for ZOSTAVAX (Merck)); dose not reported). Concomitant therapy included prednisone and methotrexate. The physician reported that on approximately 25-AUG-2011, the patient developed lesions on right wrist. On 02-SEP-2011, the patient was seen in the Dermatology unit with lesions on head, trunk and extremities. The patient's shingles was described as "disseminated". Direct fluorescent antibody (DFA) was positive. VZV antigen tests were performed on 02-SEP-2011 and 06-SEP-2011 (results not provided). The patient was treated with valacyclovir hydrochloride. ON 06-SEP-2011, the patient had a dermatology follow-up where he was found to have more lesions and was admitted to the hospital. From 06-SEP-2011 to 08-SEP-2011, the patient was treated with IV acyclovir. On 08-SEP-2011, 27 lesions were counted on face. It was reported that other than rash the patient was well. The patient's maximum temperature was 98 degrees and there was no pain. On 16-SEP-2011, the patient recovered. A specimen was not collected for PCR. It was reported that a photo was taken. This is one of several reports received from the same source. No further information is available.